• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconEditor's Picks

Editor's Picks

Page 77 of 100
Photo of Bill Anderson
SuccessA year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen
By Ryan HoggDecember 24, 2024
Business colleagues meeting in modern conference room
Success2024: The year the remote work dial shifted in European bosses’ favor
By Ryan HoggDecember 24, 2024
RetailGerman medical cannabis companies aren’t coming down from their high—they‘re predicted to bring in $1 billion in sales by 2028
By Anna HeimDecember 24, 2024
Crowd of people on Grafton Street in Dublin
LifestyleExclusive: Ireland’s housing crisis is making a third of residents consider moving to a more affordable country
By Ryan HoggDecember 24, 2024
TechChina’s in the driver’s seat as EV sales are set to keep growing into 2025
By Lionel LimDecember 23, 2024
Signs against and in support of trans youth outside of the U.S. Supreme Court
LifeFleeing the country and rationing testosterone: Transgender Americans’ new reality under a Trump presidency
By Beth GreenfieldDecember 23, 2024
Retail‘People don’t want to smell like others anymore’—this largely unknown perfume brand doesn’t advertise, but its sales have still risen 50%
By Katell Prigent and AFPDecember 23, 2024
FinanceHonda comes to the rescue of a struggling Nissan as Japanese auto giants start merger talks
By AFPDecember 23, 2024
FinanceSingapore’s Straits Times Index is Southeast Asia’s best performing index for 2024—and it’s all due to its Big Three banks
By Lionel LimDecember 22, 2024
Two men in a kitchen cooking
Life4 daily habits of truly happy people
By Kristine GillDecember 21, 2024
Lynparza (olaparib), a product of Coins2Day 500 pharmaceutical firm Merck and Coins2Day 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
HealthMerck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
Novo Nordisk advertising flags and logo on facade, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
HealthNovo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
By Ryan Hogg and AFPDecember 20, 2024
Julie Sweet, chief executive officer of Accenture Plc, during a panel session on day three of the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, Jan. 18, 2024.
TechAccenture boss Julie Sweet met 30 global CEOs in the past 2 months, and nearly all of them are scrambling to roll out more AI
By Ryan HoggDecember 20, 2024
TechMalaysia’s auto industry releases its first-ever EV—but locals wonder if it’s really homegrown
By Lionel LimDecember 20, 2024
TechSoutheast Asia has $60 billion AI boom, but its own startups are missing out
By Olivia Poh, Saritha Rai and BloombergDecember 19, 2024
1...
  • 75
  • 76
  • 77
  • 78
  • 79
...100
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.